Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 12/20 | 0.74 |
| ▸ | HTR2C | P28335 | 3/20 | 0.52 |
| ▸ | HTR1A | P08908 | 4/20 | 0.45 |
| ▸ | DRD2 | P14416 | 4/20 | 0.45 |
| ▸ | HTR7 | P34969 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | NCF1 | P14598 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1775327 | 0.99 | HTR6 (0.72) | HTR6HTR2CHTR1ADRD2HTR7 | |
| SCHEMBL1778549 | 0.96 | HTR6 (0.69) | HTR6HTR2CHTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL1781144 | 0.95 | HTR6 (0.67) | HTR6HTR2CHTR1ADRD2HTR7 | |
| SCHEMBL1776331 | 0.90 | HTR6 (0.72) | HTR6HTR2CHTR1ADRD2HTR7 | |
| SCHEMBL1774802 | 0.89 | HTR6 (0.76) | HTR6HTR2CHTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL1774664 | 0.89 | HTR6 (0.71) | HTR6HTR2CHTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL1774991 | 0.88 | HTR6 (0.74) | HTR6HTR2CHTR1ADRD2HTR7 | |
| SCHEMBL1778034 | 0.86 | HTR6 (0.67) | HTR6HTR2CHTR1ADRD2HTR7 | |
| SCHEMBL1775290 | 0.85 | HTR6 (0.70) | HTR6HTR2CHTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL1778427 | 0.85 | HTR6 (0.66) | HTR6HTR2CHTR1ADRD2HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7943639-B2 | Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss | PROXIMAGEN LIMITED (GB) | 2011-05-17 | — | — | US | claimed |